Allianz Asset Management’s St Jude Medical STJ Stock Holding History

Allianz Asset Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,600	Closed	-$1.4M	–	2743
2016 Q3	$1.4M	Buy	17,600 +11,800	+203%	+$953K	﹤0.01%	2109
2016 Q2	$452K	Buy	5,800 +800	+16%	+$57K	﹤0.01%	2331
2016 Q1	$275K	Sell	5,000 -1,000	-17%	-$54.5K	﹤0.01%	2386
2015 Q4	$371K	Buy	6,000 +2,200	+58%	+$139K	﹤0.01%	2270
2015 Q3	$240K	Sell	3,800 -15,500	-80%	-$1.11M	﹤0.01%	2243
2015 Q2	$1.41M	Buy	+19,300	New	+$1.39M	﹤0.01%	1841

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Allianz Asset Management's STJ Position: Q1 2017 in Review

Allianz Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 267,144 shares — an estimated $21.4M sold.

Allianz Asset Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $79.9M in Q3 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Allianz Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Allianz Asset Management sold 267,144 St Jude Medical shares in Q1 2017, an estimated $21.4M.
Allianz Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
Allianz Asset Management's St Jude Medical position peaked at $79.9M in Q3 2015.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Allianz Asset Management's 13F filing for Q1 2017, filed 15 May 2017.